Lausanne, Switzerland, July 12, 2022 - Saphetor, a global precision medicine company and the creator of VarSome, The Human Genomics Community and variant interpretation platform, announced today a partnership with PTC Therapeutics International...
Lausanne, Switzerland, July 12, 2022 - Saphetor, a global precision medicine company and the creator of VarSome, The Human Genomics Community and variant interpretation platform, announced today a partnership with PTC Therapeutics International...
Saphetor was featured in Nature Portfolio's Biopharma Dealmakers this week. The article explains how and why Saphetor developed VarSome. You can read the full article here.
VarSome is sponsoring this year'sAmerican Society of Human Genetics Virtual Annual Meeting, October 18-22.
Saphetor was featured in a Forbes article this week, highlighting the companies doing great work in the UK genomics ecosystem. The article covers our founder and CEO, Andreas Massouras, VarSome, and the incredible growth of the company through smart...
VarSome Suite is brought to you by Saphetor SA.
© 2024 Saphetor SA – All Rights Reserved.